Navigation Links
Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
Date:2/20/2013

LA JOLLA, Calif., Feb. 20, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported its financial results for the fourth quarter and year-ended December 31, 2012 and recent company highlights.

"In 2012, we successfully achieved significant strategic and financial objectives that have enabled Regulus to become a publicly-traded biopharmaceutical company. In particular, we successfully completed our initial public offering, formed alliances with new partners and expanded existing relationships with our pre-existing partners.  Our strategic relationships provide therapeutic expertise that will support our growing microRNA therapeutic platform," said Kleanthis G. Xanthopoulos , Ph.D., President and CEO of Regulus.  "With our solid strategic foundation in place, we are now focused on building a meaningful clinical portfolio.  We continue to advance our partnered and proprietary programs toward the clinic and look forward to nominating our first microRNA candidate for clinical development in the first half of this year." 

"Regulus continues to maintain a strong balance sheet, ending 2012 with greater than $98 million in cash," said Garry E. Menzel , Ph.D., Chief Operating Officer and Executive Vice President of Finance. "Our solid financial position should enable us to operate into 2016 and execute on our current research and development objectives."

Fourth Quarter 2012 and Recent Corporate Highlights

  • Presented Positive Preclinical Data on miR-21 at Kidney Week 2012.
    '/>"/>

  • SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
    2. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
    3. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
    4. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
    5. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
    6. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
    7. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
    8. Regulus Appoints Mark G. Foletta to its Board of Directors
    9. Regulus to Present at Two Upcoming Investor Conferences
    10. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
    11. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... 31, 2015  Boston Children,s Hospital physicians report ... printing of their anatomy before undergoing high-risk brain ... (abnormalities in the brain,s blood vessels) that posed ... in the Journal of Neurosurgery: Pediatrics , ... and synthetic resins to create custom, high-fidelity models ...
    (Date:7/31/2015)...  Semler Scientific, Inc. (Nasdaq: SMLR ), a ... insurers and physician groups, today reported financial results for ... "In the second quarter of 2015, Semler reported ... 54%, quarter over quarter revenue growth of 8%, and ... FloChec® units of 18%," said Doug Murphy-Chutorian, M.D., chief ...
    (Date:7/30/2015)... Edwards Lifesciences Corporation (NYSE: EW ), the ... monitoring, today announced that Robert A. Ingram has ... is an ardent champion for innovation in the lifesciences industry, ... on Edwards, board as we pursue our focused innovation strategy," ... "Bob has provided a valuable perspective to our board, drawing ...
    Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
    ... Results in Patients With Follicular Lymphoma Reported,Today ... 2007 /PRNewswire/ -- GlaxoSmithKline plc,announced today long-term ... of a,single one-week course of frontline treatment ... I-131 Tositumomab) in,76 patients with newly diagnosed ...
    ... PARIS--(BUSINESS WIRE)--Jun 4, 2007 - Hemispherx Biopharma, ... the clinical,development of new drug entities for ... a new scientific report on the,activity of ... anti-influenza agents against highly pathogenic avian,influenza (HPAI), ...
    Cached Medicine Technology:8-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7Hemispherx Presents Evidence of Ampligen Synergies with Existing,Antivirals at International Avian Influenza Conference 2Hemispherx Presents Evidence of Ampligen Synergies with Existing,Antivirals at International Avian Influenza Conference 3
    (Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form of surgery, it ... made more effective and less intrusive and painful. Leading these advances in the ... Dr. Loria currently stands as the only doctor in the United States who is ...
    (Date:7/31/2015)... ... , ... The alarm was ringing. Hugh Chatfield, survivor of a severe 1987 brain injury, almost ... his equipment was set up to depict the newly poured concrete. With a clear view ... photo speaks for itself. Chatfield is also a highly praised safety and drug education speaker/comedian. ...
    (Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... in Birmingham. The U.S. Women's National Soccer Team will face the Australia Women's National ... Thursday, September 17th at Ford Field in Detroit and the second match will occur ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of authentic ... Soccer Team will face the Australia Women's National Team in conjunction with their Victory Tour ... 5-2. Carli Lloyd from the USA team was awarded the Golden Ball as the ...
    (Date:7/31/2015)... ... 2015 , ... ZH Healthcare announces a new cloud based service delivering Health ... as a Service (HITaaS) is a Healthcare dedicated cloud based service that sits over ... HITaaS manages all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, ...
    Breaking Medicine News(10 mins):Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Cheap USA vs. Australia Tickets at Ford Field in Detroit, MI: Ticket Down Slashes Ticket Prices for Australia vs. USWNT International Friendly Match at Ford Field 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4
    ... News) -- Many seniors may be at increased risk for ... treat thyroid problems, a new study says. The findings ... elderly patients with thyroid problems and that regular dose monitoring ... said. Reporting in the online April 28 edition of ...
    ... THURSDAY, April 28 (HealthDay News) -- Rising rates of ... cause for concern because excess weight is associated with ... In people with arthritis, obesity is associated with ... total joint replacement and poor outcomes after joint replacement. ...
    ... THURSDAY, April 28 (HealthDay News) -- Memory in monkeys and ... says. Experiments with rhesus monkeys showed that, like people, ... ability to identify something when you see it. Recall is ... study appears online April 28 in the journal Current ...
    ... News) -- Your social status affects how your brain ... the new study, brain activity in volunteers was measured ... increased brain activity when shown information about others at ... had greater response to others like them, the investigators ...
    ... which combines interval training and healthy eating practices seems ... according to the results of a new study from ... physical activity (PIC Centre). Results of the study were ... in Montreal. Within the framework of this study, ...
    ... oncologist practiced were two factors that strongly influenced the choice ... to an article published April 29 online in the ... IMRT and the cost of radiation therapy increased sharply over ... delivery technique that modulates the radiation beams to conform to ...
    Cached Medicine News:Health News:Thyroid Drugs May Raise Fracture Risk in Elderly 2Health News:Rising Obesity Rates Add to Arthritis Woes in U.S. 2Health News:Shared Social Status Boosts Brain Activity, Research Shows 2Health News:Obesity: Conclusive results for the Montreal Heart Institute's EPIC Centre Kilo-Actif program 2Health News:Use of costly breast cancer therapy strongly influenced by reimbursement policy 2
    Hartman Mosquito forceps, straight, 3.5"....
    Curved 20 mm serrated jaws. Ring handle with ratchet lock and dull finish. Most popular size or model. Overall length 3.9 inches...
    Shafts angled 45 degrees with 10 mm jaws. Serrated handle with polished finish. Crisscross serrated jaws. Most popular size or model....
    Straight shafts with 16 mm long platform. Lengthwise serrated jaws with cross serrated tips. Serrated handle with polished finish. Platform: 2.4 mm wide....
    Medicine Products: